Products for Research Use Only
RegisterLogin

Ogalvibart

CAT: 0931-T74426-01Size: 5 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0931-T74426-01Size:5 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
CAS Number
2599039-60-6
Target
SARS-CoV
Related Pathways
Microbiology/Virology
Bioactivity
Ogalvibart (C-135-LS), a humanized anti-SARS-CoV-2 IgG1 type monoclonal antibody, specifically targets and binds to the spike (S) glycoprotein receptor-binding domain (RBD) of the SARS-CoV-2 virus. When combined with C144LS in a 1:1 ratio, Ogalvibart demonstrates significant preventive activity and effectively prevents the progression of COVID-19 in a rhesus monkey disease model [1].
Shipping Conditions
Ice Packs
Storage Temperature
-20°C

Alternative Products

CatalogName
HY-145644-01Ogalvibart
GTR18338048-01Ogalvibart Antibody
DVV00329Research Grade Ogalvibart
E55B0887Ogalvibart (Reference antibody)
ICH5725-50mgOgalvibart Biosimilar - Research Grade
GTR18780215-01(Ogalvibart) Biosimilar Reference Antibody
GTR18697217-01Ogalvibart Human Monoclonal Antibody
A135619Ogalvibart Biosimilar (Monoclonal, IgG1, kappa)
RA0658-01Ogalvibart (Biosimilar Reference Antibody) (SARS-CoV-2 Spike RBD)
PX-TA1870-01Ogalvibart Biosimilar - Anti-SARS-CoV-2 Spike RBD mAb - Research Grade

Popular Products